SKYE Insider Trading Activity and SEC Form 4 Filings
SKYE insider trading summary
Over the past 12 months, insiders at Skye Bioscience, Inc. (SKYE) reported 135 sales worth $4.0M by 9 insiders and no open-market purchases on SEC Form 4. Net insider selling was $4.0M.
Latest SKYE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 23, 2026 | John D Diekman | 10% Owner | Sell | $185K (114,851 @ $1.61) |
| Sep 23, 2026 | 5AM Partners VII, LLC | Insider | Sell | $7K (4,528 @ $1.61) |
| Sep 23, 2026 | 5AM Partners II, LLC | 10% Owner | Sell | $185K (114,851 @ $1.61) |
| Sep 23, 2026 | 5am Co-Investors II LP | 10% Owner | Sell | $185K (114,851 @ $1.61) |
| Sep 23, 2026 | Kush Parmar | 10% Owner | Sell | $185K (114,851 @ $1.61) |
| Sep 23, 2026 | Scott M Rocklage | 10% Owner | Sell | $185K (114,851 @ $1.61) |
| Sep 23, 2026 | 5AM Partners VII, LLC | Insider | Sell | $185K (114,851 @ $1.61) |
| Sep 23, 2026 | 5AM Ventures VII, L.P. | 10% Owner | Sell | $185K (114,851 @ $1.61) |
| Sep 23, 2026 | 5AM Ventures II LP | 10% Owner | Sell | $185K (114,851 @ $1.61) |
| Sep 23, 2026 | 5AM Ventures VII, L.P. | 10% Owner | Sell | $7K (4,528 @ $1.61) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.